Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):605–609. doi: 10.1038/bjc.1993.394

Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.

A Rosen 1, M Klein 1, M Lahousen 1, A H Graf 1, A Rainer 1, N Vavra 1
PMCID: PMC1968398  PMID: 8353051

Abstract

Incidence and prognostic factors of primary carcinoma of the Fallopian tube were studied in a retrospective multi-centre analysis of 115 women during the period 1980 to 1990. Data of 28 departments (university as well as general hospitals) were included in the present study which was designed to evaluate the current diagnosis and treatment of carcinoma of the Fallopian tube in Austria, and to compare the results with those from the literature. Stages were classified according to the modified FIGO-system for ovarian cancer; grading followed the criteria of Hu et al. (1950). The mean age of the patients was 62.5 years. Forty-seven (40.9%) tumours were found to be in stage I, 20 (17.4%) in stage II, 34 (29.6%) in stage III, and 14 (12.1%) in stage IV. In 82 patients, the tumour could be completely removed. The surgical method applied in 95 cases was removal of the uterus, the adnexa, and/or the omentum, or lymph nodes. Postoperatively patients underwent adjuvant therapy which was either irradiation (n = 40; 34.8%), or chemotherapy (n = 49; 42.6%); 26 women (22.6%) had no therapy after operation. The 5-year survival rate for all stages was 36.5%. In stages I and II the 5-year survival was 50.8% compared to 13.6% in stages III and IV. FIGO-stage I and II and a residual tumour less than 2 cm in advanced disease had a prognostically favourable impact, which was proven in univariate as well as multivariate analysis.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berek J. S., Hacker N. F., Lagasse L. D., Nieberg R. K., Elashoff R. M. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol. 1983 Feb;61(2):189–193. [PubMed] [Google Scholar]
  2. Böhme M., Donat H., Baumann D. Das primäre Tubenkarzinom. Zentralbl Gynakol. 1992;114(5):244–248. [PubMed] [Google Scholar]
  3. Denham J. W., Maclennan K. A. The management of primary carcinoma of the fallopian tube. Experience of 40 cases. Cancer. 1984 Jan 1;53(1):166–172. doi: 10.1002/1097-0142(19840101)53:1<166::aid-cncr2820530129>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  4. Dodson M. G., Ford J. H., Jr, Averette H. E. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol. 1970 Dec;36(6):935–939. [PubMed] [Google Scholar]
  5. Eddy G. L., Copeland L. J., Gershenson D. M., Atkinson E. N., Wharton J. T., Rutledge F. N. Fallopian tube carcinoma. Obstet Gynecol. 1984 Oct;64(4):546–552. [PubMed] [Google Scholar]
  6. Engeler V., Reinisch E., Schreiner W. E. Das primäre Tuben-karzinom--Eine klinische Studie an 37 Patientinnen. Geburtshilfe Frauenheilkd. 1981 May;41(5):325–329. doi: 10.1055/s-2008-1036802. [DOI] [PubMed] [Google Scholar]
  7. GREEN T. H., Jr, SCULLY R. E. Tumors of the fallopian tube. Clin Obstet Gynecol. 1962 Sep;5:886–906. doi: 10.1097/00003081-196209000-00022. [DOI] [PubMed] [Google Scholar]
  8. HU C. Y., TAYMOR M. L., HERTIG A. T. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1950 Jan;59(1):58-67, illust. doi: 10.1016/0002-9378(50)90341-3. [DOI] [PubMed] [Google Scholar]
  9. Hanton E. M., Malkasian G. D., Jr, Dahlin D. C., Pratt J. H. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1966 Mar 15;94(6):832–839. [PubMed] [Google Scholar]
  10. Kubista E., Kupka S. Klinische Problematik, Therapie und Prophylaxe des primären Tubenkarzinoms. Geburtshilfe Frauenheilkd. 1977 Dec;37(12):1044–1049. [PubMed] [Google Scholar]
  11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  12. McMurray E. H., Jacobs A. J., Perez C. A., Camel H. M., Kao M. S., Galakatos A. Carcinoma of the fallopian tube. Management and sites of failure. Cancer. 1986 Nov 1;58(9):2070–2075. doi: 10.1002/1097-0142(19861101)58:9<2070::aid-cncr2820580918>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  13. Morris M., Gershenson D. M., Burke T. W., Kavanagh J. J., Silva E. G., Wharton J. T. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec;76(6):1020–1024. [PubMed] [Google Scholar]
  14. Pakisch B., Poschauko J., Stücklschweiger G., Poier E., Lahousen M., Pickel H., Kohek P., Klug P., Hackl A. Die Behandlung des primären Karzinoms der Tuba Fallopii. Geburtshilfe Frauenheilkd. 1990 Aug;50(8):593–596. doi: 10.1055/s-2008-1026307. [DOI] [PubMed] [Google Scholar]
  15. Pfeiffer P., Mogensen H., Amtrup F., Honore E. Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period. Acta Oncol. 1989;28(1):7–11. doi: 10.3109/02841868909111173. [DOI] [PubMed] [Google Scholar]
  16. Podratz K. C., Podczaski E. S., Gaffey T. A., O'Brien P. C., Schray M. F., Malkasian G. D., Jr Primary carcinoma of the fallopian tube. Am J Obstet Gynecol. 1986 Jun;154(6):1319–1326. doi: 10.1016/0002-9378(86)90719-2. [DOI] [PubMed] [Google Scholar]
  17. Raju K. S., Barker G. H., Wiltshaw E. Primary carcinoma of the fallopian tube. Report of 22 cases. Br J Obstet Gynaecol. 1981 Nov;88(11):1124–1129. doi: 10.1111/j.1471-0528.1981.tb01766.x. [DOI] [PubMed] [Google Scholar]
  18. Roberts J. A., Lifshitz S. Primary adenocarcinoma of the fallopian tube. Gynecol Oncol. 1982 Jun;13(3):301–308. doi: 10.1016/0090-8258(82)90067-1. [DOI] [PubMed] [Google Scholar]
  19. Schiller H. M., Silverberg S. G. Staging and prognosis in primary carcinoma of the fallopian tube. Cancer. 1971 Aug;28(2):389–395. doi: 10.1002/1097-0142(197108)28:2<389::aid-cncr2820280219>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  20. Sevelda P., Rosen A., Denison U., Barrada M., Spona J., Salzer H. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels? Gynecol Oncol. 1991 Nov;43(2):154–158. doi: 10.1016/0090-8258(91)90063-b. [DOI] [PubMed] [Google Scholar]
  21. Tamimi H. K., Figge D. C. Adenocarcinoma of the uterine tube: potential for lymph node metastases. Am J Obstet Gynecol. 1981 Sep 15;141(2):132–137. doi: 10.1016/s0002-9378(16)32579-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES